Poma Eric E is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $50K.
Profile
Eric E. Poma is the Chief Executive Officer and Director of Calidi Biotherapeutics, Inc., a clinical-stage immuno-oncology company focused on developing therapies to combat cancer. He has been involved in the company's strategic direction and operations, particularly in advancing its stem cell-based platforms.
Eric E. Poma is the Chief Executive Officer and Director of Calidi Biotherapeutics, Inc., a clinical-stage immuno-oncology company focused on developing therapies to combat cancer. He has been involved in the company's strategic direction and operations, particularly in advancing its stem cell-based platforms.…
Has Poma Eric E been buying or selling stock?
Recorded transactions: 2 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
Where can I see all of Poma Eric E's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
